Energy
NASRDA says Nigeria to experience total lunar eclipse on Monday


By: Ikenna Oluka
The National Space Research and Development Agency (NASRDA) on Friday said Nigeria will join other countries of the world to experience total lunar eclipse on Monday.
The information was contained in a statement issued to NAN by Dr Felix
Alle, the Head, Media and Public Communications of the agency in Abuja.
According to Alle, lunar eclipse is one in which the moon appears darkened as
it passes into the earth’s shadow.
He stated that “lunar eclipse occurs only when the sun, earth and moon
are exactly aligned with the earth between the two.
“There will be a lunar eclipse over Nigeria on Monday, Jan. 21, 2019.
“The eclipse, expected to be total, will begin in the evening of Sunday and end
on Monday.
“The eclipse will start across Nigeria in the early hours of Monday at
approximately 3.36 a.m. to reach its maximum
at 6.12 a.m. and end at about 6.51 a.m.
“The total duration of the occurrence over Nigeria will be three hours and 15
minutes.”
The media head said that the lunar eclipse would by 4.33 a.m. become
partial eclipse, where the moon would start getting red.
He added that “at exactly 5.41 a.m., a maximum eclipse of the moon which may be
visible to human sight will be witnessed, while the moon eclipse is expected to
end at 6.43 a.m.”
The communications officer stated that the eclipse was expected to take
place across North, South America, Western Europe, North and West Africa and
Asia.
He said that the year’s total lunar eclipse would be the last eclipse to be
experienced until 2021.
-



News4 days ago‘You escape, or you die’: African men say Russia duped them into fighting in Ukraine
-



Hospitality2 days agoThe Nature Conservancy and FSC Africa Sign Strategic Partnership to Strengthen Sustainable Forest Management Across Africa
-



Transport3 days agoAkin Fadeyi Foundation unveils new advocacy campaign to curb road accidents
-



Energy2 days agoPayment Security Remains Biggest Barrier to Bankable Gas and Power Projects — FirstCap MD






